MarketBeat aggregated stock performance data for Adicet Bio, Inc., which trades on Nasdaq, while Jefferies Financial Group issued a rating and price objective.
4 reports, 1 independent
Updated Sat 00:00
No new developments lately
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat aggregated stock performance data for Adicet Bio, Inc., which trades on Nasdaq, while Jefferies Financial Group issued a rating and price objective.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies Financial Group acquired a new stake in Adicet Bio and upgraded its rating to strong-buy.1 source
MarketBeat aggregated data on Adicet Bio, Inc., which trades on Nasdaq, and Jefferies Financial Group issued a rating and price objective.1 source
Keep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Nasdaq
American fully electronic stock exchange
-
Jefferies Financial Group
American financial services company
Related events
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- MarketBeat aggregated analyst reports on Best Buy stock on September 13, 2026.
- MarketBeat aggregated analyst ratings and analyzed stock performance for Urban Outfitters on August 31, 2026.
- MarketBeat aggregates financial news about Kingspan Group, a company based in Ireland, noting that analyst upgrades are affecting stock valuation.
- Nextpower Inc. was listed on the Nasdaq electronic stock exchange, with data aggregated by MarketBeat.